Cancer risks in thiazolidinedione users compared to other anti-diabetic agents

Koro, Carol, Barrett, Steven, Qizilbash, Nawab·2007·Pharmacoepidemiology and Drug Safety
DOI 10.1002/pds.1352

Cited by (107)

Items 101–107 of 107

  1. Current awareness: Pharmacoepidemiology and drug safety
    2007 · Pharmacoepidemiology and Drug Safety
  2. Diabetes and Cancer
    Riccardo Vigneri, Laura Sciacca · 2018 · Endocrinology
  3. Diabetes and Cancer
    Riccardo Vigneri, Laura Sciacca · 2019 · Endocrinology
  4. Diabetes and Cancer
    Riccardo Vigneri, Laura Sciacca · 2020 · Endocrinology
  5. Rôle du système IGF-1/insuline dans le Myélome Multiple
    Anne Catherine Sprynski · 2009 · HAL
  6. Pharmacological mechanisms and clinical impacts of antidiabetic drugs on colorectal cancer risk: a systematic review
    Y Y Yang, Kan Wang · 2026 · Frontiers in Pharmacology
  7. Association Between Thiazolidinediones and Solid Tumors in Patients with Diabetes: Evidence from the US Veteran Healthcare System
    Craig Carl Teerlink, Tyler J. Nelson, Kathryn M. Pridgen, Fatai Y. Agiri, Mulugeta Gebregziabher, Andrew D. Schreiner, Kinfe Gebreegziabher Bishu, Hermes J. Florez, Richard L. Hauger, Julie Ann Lynch · 2026 · Diabetology